Dr. Gaurav Laroia appointed as GM for Roche Diabetes Care India

02 January 2019 | News

New General Manager joins from Roche Singapore where he was heading the Programme Management Office, APAC for Roche Pharmaceuticals.

Roche Diabetes Care India, a pioneer in the development of blood glucose monitoring systems, and a global leader for diabetes management systems and services, announced the appointment of Dr. Gaurav Laroia as General Manager for its India operations. He assumes his new role with effect from 01st January, 2019. Gaurav will report to Pedro Goncalves, Head of Roche Diabetes Care Asia Pacific and will be a member of the Roche Diabetes Care Asia Pacific Leadership Team.

He relocates to Mumbai from his current role as Head of Program Management Office (PMO) APAC in Singapore. Gaurav has more than 18 years of experience in commercial operations, business development, and management consulting in healthcare-related multinational organisations in India, Singapore and the USA. He holds a Ph.D. in Molecular & Cellular Biology from New York University School of Medicine, USA and a Masters in Genetics from the University of Cambridge, UK.

Dr. Gaurav Laroia, GM, Roche Diabetes Care India, said, “I am excited to be heading the India entity of Roche Diabetes Care. This role that comes with great responsibility towards patient care and I look forward to driving the development of integrated diabetes management solutions. Roche persistently endeavours to improve the quality of life and provide cohesive solutions for people with diabetes and I am privileged to be part of this journey. India is a very important market for Roche and our aspiration in the near future will be to be India’s topmost integrated diabetes solutions provider, touching millions of lives who need smart solutions for diabetes.”

About Roche Diabetes Care

Roche Diabetes Care is pioneering innovative diabetes technologies and services for more than 40 years. Being a global leader in integrated diabetes management, more than 5,000 employees in over 100 markets worldwide work every day to support people with diabetes and those at risk to achieve more time in their target range and experience true relief from the daily therapy routines. Roche Diabetes Care collaborates with caregivers, healthcare providers and payers to optimally manage this complex condition and contribute to sustainable care structures. Under the brand Accu-Chek and in collaboration with partners, Roche Diabetes Care creates value by providing integrated solutions to monitor glucose levels, deliver insulin and track as well as contextualize relevant data points for a successful therapy. By establishing a leading open ecosystem, connecting devices, digital solutions, Roche Diabetes Care will enable optimal personalised diabetes management and thus improve therapy outcomes. Since 2017, mySugr with its world-leading mobile diabetes management app and services is part of Roche Diabetes Care.


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account